Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GrpE protein homolog 1, mitochondrial (GRPEL1) is a co-chaperone in the mitochondrial matrix that acts as the main nucleotide exchange factor (NEF) for mitochondrial Hsp70 (also known as mortalin). GRPEL1 is essential for protein folding, complex assembly, and the import of proteins into mitochondria by facilitating the exchange of ADP for ATP in the chaperone cycle. It forms homodimers and interacts directly with mortalin (mtHSP70) to promote substrate release and maintain proteostasis within the mitochondria. Disruption or loss of GRPEL1 impairs mitochondrial function, resulting in rapid muscle atrophy and systemic bioenergetic failure in mammals. It is not currently a therapeutic drug target but is indispensable for normal mitochondrial biology and cellular metabolism[1][2][3][5][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GrpE protein homolog 1, mitochondrial (GRPEL1).